Bodo Brückner, Eva-Maria Gottmann and Christian Tidona lead a multidisciplinary team with entrepreneurial and self-employment background.
Since 2009 they are teaching life science Master students (and since last year also PhDs) at Heidelberg University how to develop and present a business idea - the program is called "Biotech Entrepreneurship Training Program" (BETP). In 2013 BioMed X Innovation Center, BioRN Cluster Management and Heidelberg University established the lectures series "Biotech Entrepreneurship and Leadership Lectures" (BELL) where successful entrepreneurs and business leaders share their experiences with students and young professionals.
As the number of participants is increasing, the team decided to create this website in order to bundle their entrepreneurship activities at www.biotech-entrepreneurship.com.
Biotech Entrepreneurship Training Program Heidelberg 2016/17Eva-Maria Gottmann
Biotech Entrepreneurship Training Program provides an in-depth introduction to entrepreneurship with a focus on biotechnology/medtech for Masters students and postdocs of biotechnology and related fields (life sciences or health technology).
You will learn:
How to set up a business model using Alexander Osterwalder´s business model canvas
The concept of the investor readiness level as applied to different healthtech/biotech segments (e.g., therapeutics, diagnostics, digital health)
Different sources of capital (debt versus equity) and funding (Angels, VCs, crowd-funding platforms) for startups
How a Venture Capitalist works
Different types of intellectual property and their relevance for biotech/medtech
How to structure and design a pitch presentation
How to present a business idea in front of a critical audience
How to organize yourself as team by using online collaboration tools
Event Report - Vietnam Youth to Business Forum July 2014Y2B2014
Vietnam Youth to Business Forum July 2014 is the 6th Vietnamese version of Youth to Business Forum, powered by AIESEC in Vietnam. With 500 student attendants and 20 business partners, the event is the largest annual event of AIESEC, aiming to narrow the gap between Youth and Business, from which prepare students with business mindset and knowledge that can help them better orient their future careers.
Alliance for CME 2009 Presentation, Wake me Up Before it’s Over:Bringing out...Wendy999
2009 ACME Presentation, co-presented with Marissa Seligman, that tackles strategies to bring innovation to live continuing medical education activities.
Biotech Entrepreneurship Training Program Heidelberg 2016/17Eva-Maria Gottmann
Biotech Entrepreneurship Training Program provides an in-depth introduction to entrepreneurship with a focus on biotechnology/medtech for Masters students and postdocs of biotechnology and related fields (life sciences or health technology).
You will learn:
How to set up a business model using Alexander Osterwalder´s business model canvas
The concept of the investor readiness level as applied to different healthtech/biotech segments (e.g., therapeutics, diagnostics, digital health)
Different sources of capital (debt versus equity) and funding (Angels, VCs, crowd-funding platforms) for startups
How a Venture Capitalist works
Different types of intellectual property and their relevance for biotech/medtech
How to structure and design a pitch presentation
How to present a business idea in front of a critical audience
How to organize yourself as team by using online collaboration tools
Event Report - Vietnam Youth to Business Forum July 2014Y2B2014
Vietnam Youth to Business Forum July 2014 is the 6th Vietnamese version of Youth to Business Forum, powered by AIESEC in Vietnam. With 500 student attendants and 20 business partners, the event is the largest annual event of AIESEC, aiming to narrow the gap between Youth and Business, from which prepare students with business mindset and knowledge that can help them better orient their future careers.
Alliance for CME 2009 Presentation, Wake me Up Before it’s Over:Bringing out...Wendy999
2009 ACME Presentation, co-presented with Marissa Seligman, that tackles strategies to bring innovation to live continuing medical education activities.
Research exploring clinician learning is of little value if it is not shared and leveraged broadly by those within the CME community to drive innovation and improve educational planning. This session is moderated by Jeremy C. Lundberg, MSSW, CEO of EthosCE Learning Management System and will introduce three new and emerging data sets that have been collected by Brian S. McGowan, PhD, Chief Learning Officer of ArcheMedEx.com. Dr. McGowan will structure each data set to highlight the problem, the methods of exploration, and the data or conclusion that could be drawn. These new ideas will then be put into the context of the educational planning process with the goal of allowing those within the CME community to effectively leverage these data and lessons to immediately impact their planning processes.
VIDEO CAN BE VIEWED AT: https://www.youtube.com/watch?v=qpGmtaxKR70
Slide set from presentation at TEDx Event ("Inspiring Innovation")
hosted by University of Ludwigshafen, HSLU.
For Further Information / Additional Sources:
SYNAGIS:
https://www.synagis.com/
APPLE:
Steve Jobs introduces Original iPod - Apple Special Event (2001). https://www.youtube.com/watch?v=SYMTy6fchiQ
RED BULL:
http://energydrink-de.redbull.com/unternehmen
Keller, KL (2008). Red Bull: Building brand equity in non-traditional ways. In: Best Practice Cases in Branding - Lessons from the World's Strongest Brands. Pearson Prentice Hall.
PUSSANGA:
http://www.pussanga.com/
SRH UNIVERSITY:
http://www.hochschule-heidelberg.de/de/studium/nach-dem-core-prinzip-studieren/
https://www.youtube.com/watch?v=JcMUCnDfAXc
ALTERNATIVE TEACHING METHODS:
http://www.slideshare.net/welfordla/sm-love-story
https://www.youtube.com/watch?v=JcMUCnDfAXc
Nanyang Technological University (NTU) Talent Seminar Singapore 2014Marielle Reussink
Every day we read that the expectations of talent are changing; that what we did yesterday to attract and engage this talent may not necessarily work today, and that if we truly want to win their hearts and minds, we need to do more than offering an attractive compensation package.What is it that this generation wants? How can employers engage and attract this generation to join their organisations long-term? Leveraging data from the Universum Top 100 Ideal Employers Singapore student survey 2014, the keynote speaker Ms Marielle Reussink provides actionable insights on Engaging and Attracting Millennial Talent in Singapore through her presentation at the NTU Talent Seminar 2014.
Keynote: The Future of Healthcare Events Len Starnes
Keynote presented at 'The Future of Healthcare Events Forum', Malmö, Sweden, 12 - 14 Feb 2019. Forum attendees were events professionals but insights have significant relevance for all healthcare stakeholders.
NVBDCP.pptx Nation vector borne disease control programSapna Thakur
NVBDCP was launched in 2003-2004 . Vector-Borne Disease: Disease that results from an infection transmitted to humans and other animals by blood-feeding arthropods, such as mosquitoes, ticks, and fleas. Examples of vector-borne diseases include Dengue fever, West Nile Virus, Lyme disease, and malaria.
Research exploring clinician learning is of little value if it is not shared and leveraged broadly by those within the CME community to drive innovation and improve educational planning. This session is moderated by Jeremy C. Lundberg, MSSW, CEO of EthosCE Learning Management System and will introduce three new and emerging data sets that have been collected by Brian S. McGowan, PhD, Chief Learning Officer of ArcheMedEx.com. Dr. McGowan will structure each data set to highlight the problem, the methods of exploration, and the data or conclusion that could be drawn. These new ideas will then be put into the context of the educational planning process with the goal of allowing those within the CME community to effectively leverage these data and lessons to immediately impact their planning processes.
VIDEO CAN BE VIEWED AT: https://www.youtube.com/watch?v=qpGmtaxKR70
Slide set from presentation at TEDx Event ("Inspiring Innovation")
hosted by University of Ludwigshafen, HSLU.
For Further Information / Additional Sources:
SYNAGIS:
https://www.synagis.com/
APPLE:
Steve Jobs introduces Original iPod - Apple Special Event (2001). https://www.youtube.com/watch?v=SYMTy6fchiQ
RED BULL:
http://energydrink-de.redbull.com/unternehmen
Keller, KL (2008). Red Bull: Building brand equity in non-traditional ways. In: Best Practice Cases in Branding - Lessons from the World's Strongest Brands. Pearson Prentice Hall.
PUSSANGA:
http://www.pussanga.com/
SRH UNIVERSITY:
http://www.hochschule-heidelberg.de/de/studium/nach-dem-core-prinzip-studieren/
https://www.youtube.com/watch?v=JcMUCnDfAXc
ALTERNATIVE TEACHING METHODS:
http://www.slideshare.net/welfordla/sm-love-story
https://www.youtube.com/watch?v=JcMUCnDfAXc
Nanyang Technological University (NTU) Talent Seminar Singapore 2014Marielle Reussink
Every day we read that the expectations of talent are changing; that what we did yesterday to attract and engage this talent may not necessarily work today, and that if we truly want to win their hearts and minds, we need to do more than offering an attractive compensation package.What is it that this generation wants? How can employers engage and attract this generation to join their organisations long-term? Leveraging data from the Universum Top 100 Ideal Employers Singapore student survey 2014, the keynote speaker Ms Marielle Reussink provides actionable insights on Engaging and Attracting Millennial Talent in Singapore through her presentation at the NTU Talent Seminar 2014.
Keynote: The Future of Healthcare Events Len Starnes
Keynote presented at 'The Future of Healthcare Events Forum', Malmö, Sweden, 12 - 14 Feb 2019. Forum attendees were events professionals but insights have significant relevance for all healthcare stakeholders.
NVBDCP.pptx Nation vector borne disease control programSapna Thakur
NVBDCP was launched in 2003-2004 . Vector-Borne Disease: Disease that results from an infection transmitted to humans and other animals by blood-feeding arthropods, such as mosquitoes, ticks, and fleas. Examples of vector-borne diseases include Dengue fever, West Nile Virus, Lyme disease, and malaria.
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists Saeid Safari
Preoperative Management of Patients on GLP-1 Receptor Agonists like Ozempic and Semiglutide
ASA GUIDELINE
NYSORA Guideline
2 Case Reports of Gastric Ultrasound
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...GL Anaacs
Contact us if you are interested:
Email / Skype : kefaya1771@gmail.com
Threema: PXHY5PDH
New BATCH Ku !!! MUCH IN DEMAND FAST SALE EVERY BATCH HAPPY GOOD EFFECT BIG BATCH !
Contact me on Threema or skype to start big business!!
Hot-sale products:
NEW HOT EUTYLONE WHITE CRYSTAL!!
5cl-adba precursor (semi finished )
5cl-adba raw materials
ADBB precursor (semi finished )
ADBB raw materials
APVP powder
5fadb/4f-adb
Jwh018 / Jwh210
Eutylone crystal
Protonitazene (hydrochloride) CAS: 119276-01-6
Flubrotizolam CAS: 57801-95-3
Metonitazene CAS: 14680-51-4
Payment terms: Western Union,MoneyGram,Bitcoin or USDT.
Deliver Time: Usually 7-15days
Shipping method: FedEx, TNT, DHL,UPS etc.Our deliveries are 100% safe, fast, reliable and discreet.
Samples will be sent for your evaluation!If you are interested in, please contact me, let's talk details.
We specializes in exporting high quality Research chemical, medical intermediate, Pharmaceutical chemicals and so on. Products are exported to USA, Canada, France, Korea, Japan,Russia, Southeast Asia and other countries.
The prostate is an exocrine gland of the male mammalian reproductive system
It is a walnut-sized gland that forms part of the male reproductive system and is located in front of the rectum and just below the urinary bladder
Function is to store and secrete a clear, slightly alkaline fluid that constitutes 10-30% of the volume of the seminal fluid that along with the spermatozoa, constitutes semen
A healthy human prostate measures (4cm-vertical, by 3cm-horizontal, 2cm ant-post ).
It surrounds the urethra just below the urinary bladder. It has anterior, median, posterior and two lateral lobes
It’s work is regulated by androgens which are responsible for male sex characteristics
Generalised disease of the prostate due to hormonal derangement which leads to non malignant enlargement of the gland (increase in the number of epithelial cells and stromal tissue)to cause compression of the urethra leading to symptoms (LUTS
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journeygreendigital
Tom Selleck, an enduring figure in Hollywood. has captivated audiences for decades with his rugged charm, iconic moustache. and memorable roles in television and film. From his breakout role as Thomas Magnum in Magnum P.I. to his current portrayal of Frank Reagan in Blue Bloods. Selleck's career has spanned over 50 years. But beyond his professional achievements. fans have often been curious about Tom Selleck Health. especially as he has aged in the public eye.
Follow us on: Pinterest
Introduction
Many have been interested in Tom Selleck health. not only because of his enduring presence on screen but also because of the challenges. and lifestyle choices he has faced and made over the years. This article delves into the various aspects of Tom Selleck health. exploring his fitness regimen, diet, mental health. and the challenges he has encountered as he ages. We'll look at how he maintains his well-being. the health issues he has faced, and his approach to ageing .
Early Life and Career
Childhood and Athletic Beginnings
Tom Selleck was born on January 29, 1945, in Detroit, Michigan, and grew up in Sherman Oaks, California. From an early age, he was involved in sports, particularly basketball. which played a significant role in his physical development. His athletic pursuits continued into college. where he attended the University of Southern California (USC) on a basketball scholarship. This early involvement in sports laid a strong foundation for his physical health and disciplined lifestyle.
Transition to Acting
Selleck's transition from an athlete to an actor came with its physical demands. His first significant role in "Magnum P.I." required him to perform various stunts and maintain a fit appearance. This role, which he played from 1980 to 1988. necessitated a rigorous fitness routine to meet the show's demands. setting the stage for his long-term commitment to health and wellness.
Fitness Regimen
Workout Routine
Tom Selleck health and fitness regimen has evolved. adapting to his changing roles and age. During his "Magnum, P.I." days. Selleck's workouts were intense and focused on building and maintaining muscle mass. His routine included weightlifting, cardiovascular exercises. and specific training for the stunts he performed on the show.
Selleck adjusted his fitness routine as he aged to suit his body's needs. Today, his workouts focus on maintaining flexibility, strength, and cardiovascular health. He incorporates low-impact exercises such as swimming, walking, and light weightlifting. This balanced approach helps him stay fit without putting undue strain on his joints and muscles.
Importance of Flexibility and Mobility
In recent years, Selleck has emphasized the importance of flexibility and mobility in his fitness regimen. Understanding the natural decline in muscle mass and joint flexibility with age. he includes stretching and yoga in his routine. These practices help prevent injuries, improve posture, and maintain mobilit
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?bkling
Are you curious about what’s new in cervical cancer research or unsure what the findings mean? Join Dr. Emily Ko, a gynecologic oncologist at Penn Medicine, to learn about the latest updates from the Society of Gynecologic Oncology (SGO) 2024 Annual Meeting on Women’s Cancer. Dr. Ko will discuss what the research presented at the conference means for you and answer your questions about the new developments.
Ethanol (CH3CH2OH), or beverage alcohol, is a two-carbon alcohol
that is rapidly distributed in the body and brain. Ethanol alters many
neurochemical systems and has rewarding and addictive properties. It
is the oldest recreational drug and likely contributes to more morbidity,
mortality, and public health costs than all illicit drugs combined. The
5th edition of the Diagnostic and Statistical Manual of Mental Disorders
(DSM-5) integrates alcohol abuse and alcohol dependence into a single
disorder called alcohol use disorder (AUD), with mild, moderate,
and severe subclassifications (American Psychiatric Association, 2013).
In the DSM-5, all types of substance abuse and dependence have been
combined into a single substance use disorder (SUD) on a continuum
from mild to severe. A diagnosis of AUD requires that at least two of
the 11 DSM-5 behaviors be present within a 12-month period (mild
AUD: 2–3 criteria; moderate AUD: 4–5 criteria; severe AUD: 6–11 criteria).
The four main behavioral effects of AUD are impaired control over
drinking, negative social consequences, risky use, and altered physiological
effects (tolerance, withdrawal). This chapter presents an overview
of the prevalence and harmful consequences of AUD in the U.S.,
the systemic nature of the disease, neurocircuitry and stages of AUD,
comorbidities, fetal alcohol spectrum disorders, genetic risk factors, and
pharmacotherapies for AUD.
Knee anatomy and clinical tests 2024.pdfvimalpl1234
This includes all relevant anatomy and clinical tests compiled from standard textbooks, Campbell,netter etc..It is comprehensive and best suited for orthopaedicians and orthopaedic residents.
Couples presenting to the infertility clinic- Do they really have infertility...Sujoy Dasgupta
Dr Sujoy Dasgupta presented the study on "Couples presenting to the infertility clinic- Do they really have infertility? – The unexplored stories of non-consummation" in the 13th Congress of the Asia Pacific Initiative on Reproduction (ASPIRE 2024) at Manila on 24 May, 2024.
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...VarunMahajani
Disruption of blood supply to lung alveoli due to blockage of one or more pulmonary blood vessels is called as Pulmonary thromboembolism. In this presentation we will discuss its causes, types and its management in depth.
2. 2
Biotech
Entrepreneurship
Training Program
3 teachers
8 courses
135 participants
from 10 different
organizations
Biotech
Entrepreneurship
and Leadership
Lectures
5 editions
23 speakers
Biotech
Entrepreneurship
Online Content
Blog
190 Followers on
Twitter
284 Likes on
Facebook
Linkedin Group
4. October 12: Christian Piepenbrock, serial entrepreneur
October 26: Markus Wilhelms, usMIMA, Barcelona
November 09: Hong Cheng, Sanofi
November 23: Christian Tidona, BioMed X / BioRN Network
December 07: Thomas Schulz, Société Coopérative Healthbank, Genève
January 11: Christoph Zrenner, MedTech Accelerator Tübingen
January 25: Adrian Carter, Boehringer Ingelheim
January 27: Colin Bennet, Flames A Mile High
4
5. Alexander Würfel, AbbVie
Andrea Pfundmeier, Boxcryptor / Secomba
GmbH (Winner of the German Founder Price
2014)
Christian Tidona, BioMed X Innovation Center /
BioRN Network
Claus Kremoser, Phenex Pharmaceuticals
Colin Bennett, Flames a Mile High
Friedrich Richter, AbbVie
Georg Matheis, Novalung GmbH
Gitte Neubauer, Cellzome
Ingmar Hoerr, Curevac
Jürgen Bauer, EMBLEM Technology Transfer
5
Matthias Klaften, amcure GmbH
Marius Rosenberg, Medical Adhesive
Revolution (MAR) GmbH
Patrick Most, uniQure Germany/InoCard
Peter Johann, NGN Capital
Ralf Eckert, Leica Biosystems Nussloch GmbH
Roel Bulthuis, Merck Serono Ventures
Stefan Duhr, Nanotemper (Winner of the
German Founder Price 2014)
Thomas Höger, Apogenix GmbH
Vikas Shah, Swiscot Group (Managing
Director), Thought Strategy (Founder)
Volker Stadler, PEPperPRINT
9. • Compact course for students, PhDs, and postdocs in
Life Sciences & Health Technology at Heidelberg
University
• 2 ECTS for master students
• Started in 2009
• Participants from:
9
10. What are our goals?
• Generation of a basic understanding of intellectual
property, innovation, and economic value creation
from academic research results
• Development of a viable and compelling business
idea
• Presentation of the business idea in front of a critical
audience
10
11. How does it work?
• Basics are provided in three lectures
• Participants are grouped in “founder teams”
to jointly work on business ideas based on
current research articles or own ideas
• Teams present their business ideas
11
13. • BETP fills a gap in the curriculum on
entrepreneurship
• BETP also improves presentations skills
• Everyone would recommend it to his peers
• Peers play an important role as reason to
apply
17. “Very useful intro to
entrepreneurship.”
“Gives a new
perspective.”
“It is a great chance to learn something
that I was never told at school/university
from people who are credible.”
“Good chance to practice team
work with people who you
didn't know before.”
“It was great
fun.”
18.
19. • to get an idea about entrepreneurship in general
since it is not part of the master program
• to better understand how biotech inventions can
be developed into marketable products
• curiosity
• feeling there was a lack of economical context in
my university program
• wondering how you can start a company
• “real life” impression
• only seminar available on entrepreneurship at
Heidelberg University
20.
21. • “Highly skilled instructors; feedback on the
final presentations was very useful.”
• pitching with a team
• instructions for how to make business plan
• working out the business idea out of research
results
22. • the presentations and team work
• elaborated feedback and suggestions
• “Good atmosphere; challenging team; very
new kind of problem to solve; work together
with people of different backgrounds”
• additional material on the webpage
23. 23
Next BETP course
starts on April 27!
05:00 – 07:00 p.m.
Further information:
www.biotech-entrepreneurship.com